Despite these challenges, ChatGPT and Bard have demonstrated significant knowledge in radiology, lung cancer, neurosurgery, and ECG interpretation, with ChatGPT outperforming Bard in radiology board questions 137,138. Both chatbots have been utilized in the education of radiology residents, showcasing their potential in enhancing medical training 139,140. An integral facet of telemedicine, particularly evident post pandemic, is its significant role in mitigating physician burnout 91,92.
Future of AI in healthcare
Within each category, applications were further analyzed for innovation, scalability, translational potential, and scientific quality. The potential applications of AI in assisting clinicians with treatment decisions, particularly in predicting https://elitecolumbia.com/beyond-aesthetics-how-top-product-design-agencies-drive-business-growth-in-2025.html therapy response, have gained recognition 49. A study conducted by Huang et al. where authors utilized patients’ gene expression data for training a support ML, successfully predicted the response to chemotherapy 51. In this study, the authors included 175 cancer patients incorporating their gene-expression profiles to predict the patients’ responses to various standard-of-care chemotherapies. Notably, the research showed encouraging outcomes, achieving a prediction accuracy of over 80% across multiple drugs.
Mapping the application of artificial intelligence in traditional medicine: technical brief
Using an AI-powered tool and genomics, the researchers could predict disease more accurately and thus intervene sooner. However, clinicians cite clinical documentation and administrative tasks as EHR burdens and sources of burnout. WHO envisions a future where AI serves as a powerful force for innovation, equity, and ethical integrity in healthcare.
Shaping the future of AI in healthcare through ethics and governance
Integrating AI and other technologies into these processes will continue revolutionizing the pharmaceutical industry. In the early days of CDSS tools, many were standalone offerings that were not well integrated into clinical workflows. Today, many CDSSes are integrated into electronic health records (EHRs) to help improve deployment and gain more value from the use of these tools at the bedside. By doing so, the EHDS enables the EU to fully benefit from the potential of a safe and secure exchange, as well as the use and reuse of health data to benefit patients, researchers, innovators, and regulators. At the World Health Organization (WHO), we support the science-based adoption of Artificial Intelligence (AI) for health. Our overarching goal is to ensure that AI advancements contribute to global health in a way that is safe, ethical and equitable, with appropriate governance and regulation.
AI in cancer
New tools like ChatGPT Health and Claude for Life Sciences are enabling users to connect their health data from wearable devices directly into AI models for hyperpersonalized recommendations and to predict potential health risks. Recent efforts have focused on leveraging AI to reduce bias and improve inclusivity in biomedical research. AI tools are being developed to identify and correct demographic underrepresentation in clinical datasets, thereby improving the generalizability and equity of research findings across diverse populations. Thus, data that has already experienced human biases in the past will be susceptible to incorrect predictions or withholding of resources (46). In the mental health domain, it is important to identify organised treatment programmes an monitor the treatment that he rents and guidance from mental health specialists.
AI transforms nurse staffing from an estimation exercise to precise, data-driven models benefiting cost, care, and clinician experience. For example, surgeons can use robotic arms to conduct procedures, allowing for improved dexterity and range of motion. AI and other healthcare offerings can’t replace humans, but as these tools continue to advance, they’re showing increasing promise in augmenting the performance of the healthcare workforce. However, adoption will likely center on operational optimization, leading to automation tools deployed in areas with the highest administrative burden, such as claims management.
AI assistance in diagnostics
- Chatbots aimed at simplifying complex radiology reports have shown varied effectiveness, with errors and missing information posing potential risks to patient well-being 136.
- Its MUSA surgical robot, developed by engineers and surgeons, can be controlled via joysticks for performing microsurgery.
- Previous studies that have evaluated AI deployment in US healthcare organizations17–20 are limited in scope and took place before current generative AI has significantly impacted the healthcare industry.
- The simultaneous analysis of extensive genomic data and other clinical parameters, such as drug efficacy or adverse effects, facilitates the identification of novel therapeutic targets or the repurposing of existing drugs for new applications 42–46.
- Furthermore, CNNs require a significant amount of training data that comes in the form of medical images along with labels for what the image is supposed to be.
This lack of transparency undermines clinical trust, complicates validation of AI-driven diagnoses, and limits patient confidence in their care. For example, an AI system may suggest a diagnosis without clarifying which features influenced the result, reducing its reliability in evidence-based practice. To address this, interpretable models are needed to clarify decision-making processes, highlight key features, and foster trust among clinicians and patients 149. It is predominantly utilized for drugs with a narrow therapeutic index to avoid both underdosing insufficiently medicating as well as toxic levels. TDM aims to ensure that patients receive the right drug, at the right dose, at the right time, to achieve the desired therapeutic outcome while minimizing adverse effects 56.
The ability of AI to aid in health diagnoses also improves the speed and accuracy of patient visits, leading to faster and more personalized care. And efficiently providing a seamless patient experience allows hospitals, clinics and physicians to treat more patients on a daily basis. Under the General Data Protection Regulation (GDPR), consent is not always required for training artificial intelligence (AI) models using patient data—provided the data is fully anonymised. However, GDPR applies strictly when data is not fully anonymised, as such data is still considered personal and subject to protection.
In recent years, the rise of predictive analytics has aided providers in delivering more proactive healthcare to patients. In the era of value-based care, the capability to forecast outcomes is invaluable for developing crucial interventions and guiding clinical decision-making. AI provides a number of benefits to the field of health care, the professionals working within it, and the patients who interact with it every day. Patients may experience improved health outcomes and lower costs resulting from more efficient health services. Its technology https://www.23ch.info/what-has-changed-recently-with-8/ integrates with devices like smartwatches and ECG patches to collect a continuous stream of real-world patient data.
Need for the study
This paper aims to provide a multidisciplinary synthesis of AI applications across medicine, surgery, allied health, and biomedical research. Furthermore, we also aimed to critically evaluate the limitations and regulatory challenges of implementation. And finally we aimed to propose future research directions that can guide safe, equitable, and responsible AI integration. The review is structured to first present the history and evolution of AI, followed by its clinical and research applications, limitations, and finally, directions for future integration into healthcare systems.